When fed a high-fat diet, transgenic mice with hepatic RELMβ over-expression exhibits obvious hyperglycemia, hyperlipidemia, fatty liver, pancreatic islet enlargement, and hepatic insulin resistance [65]. The gene discussed is RETNLB; the disease is hyperlipidemia.